CinRx Pharma, LLC - Jan 6, 2022 Form 3 Insider Report for CinCor Pharma, Inc. (CINC)

Role: 10%+ Owner
Signature: CinRx Pharma, LLC, By /s/ Jonathan Isaacsohn, CEO
Stock symbol: CINC
Transactions as of: Jan 6, 2022
Transactions value $: $0
Form type: 3
Date filed: 1/10/2022, 03:12 PM
Next filing: Jan 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CINC	Common Stock						2.41M	Jan 6, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CINC	Series A Preferred Stock							Jan 6, 2022	Common Stock	630K		Direct	F1
holding	CINC	Series B Preferred Stock							Jan 6, 2022	Common Stock	592K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock and Series B Preferred Stock will automatically convert into shares of Common Stock on a 3.4:1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.